Works matching AU Auer, Michael

Results: 121
    1
    2

    Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.

    Published in:
    Annals of Clinical & Translational Neurology, 2025, v. 12, n. 2, p. 345, doi. 10.1002/acn3.52279
    By:
    • Bsteh, Gabriel;
    • Hegen, Harald;
    • Krajnc, Nik;
    • Föttinger, Fabian;
    • Altmann, Patrick;
    • Auer, Michael;
    • Berek, Klaus;
    • Kornek, Barbara;
    • Leutmezer, Fritz;
    • Macher, Stefan;
    • Monschein, Tobias;
    • Ponleitner, Markus;
    • Rommer, Paulus;
    • Schmied, Christiane;
    • Zebenholzer, Karin;
    • Zulehner, Gudrun;
    • Zrzavy, Tobias;
    • Deisenhammer, Florian;
    • Di Pauli, Franziska;
    • Pemp, Berthold
    Publication type:
    Article
    3
    4
    5
    6
    7

    Figura Etymologica.

    Published in:
    Angelaki: Journal of the Theoretical Humanities, 2012, v. 17, n. 1, p. 13, doi. 10.1080/0969725X.2012.671642
    By:
    • Auer, Michael
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis—Evidence for applying a rebaselining concept.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 9, p. 1128, doi. 10.1177/13524585241267257
    By:
    • Bsteh, Gabriel;
    • Hegen, Harald;
    • Krajnc, Nik;
    • Föttinger, Fabian;
    • Altmann, Patrick;
    • Auer, Michael;
    • Berek, Klaus;
    • Kornek, Barbara;
    • Leutmezer, Fritz;
    • Macher, Stefan;
    • Monschein, Tobias;
    • Ponleitner, Markus;
    • Rommer, Paulus;
    • Schmied, Christiane;
    • Zebenholzer, Karin;
    • Zulehner, Gudrun;
    • Zrzavy, Tobias;
    • Deisenhammer, Florian;
    • Di Pauli, Franziska;
    • Pemp, Berthold
    Publication type:
    Article
    14
    15
    16
    17
    18

    Olfactory threshold predicts treatment response in relapsing multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1541, doi. 10.1177/13524585221079744
    By:
    • Bsteh, Gabriel;
    • Hegen, Harald;
    • Berek, Klaus;
    • Altmann, Patrick;
    • Auer, Michael;
    • Di Pauli, Franziska;
    • Haider, Lukas;
    • Leutmezer, Fritz;
    • Rommer, Paulus;
    • Walchhofer, Lisa-Maria;
    • Wurth, Sebastian;
    • Zinganell, Anne;
    • Deisenhammer, Florian;
    • Berger, Thomas
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Prediction of natalizumab anti-drug antibodies persistency.

    Published in:
    Multiple Sclerosis Journal, 2019, v. 25, n. 3, p. 392, doi. 10.1177/1352458517753721
    By:
    • Deisenhammer, Florian;
    • Jank, Marlies;
    • Lauren, Anna;
    • Sjödin, Anders;
    • Ryner, Malin;
    • Fogdell-Hahn, Anna;
    • Sievers, Claudia;
    • Lindberg, Raija;
    • Jensen, Poul Erik;
    • Sellebjerg, Finn;
    • Christodoulou, Louis;
    • Birchler, Mary;
    • Pallardy, Marc;
    • Auer, Michael;
    • Liblau, Roland
    Publication type:
    Article
    25
    26

    Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 196, doi. 10.1177/1352458517740216
    By:
    • Bsteh, Gabriel;
    • Hegen, Harald;
    • Amprosi, Matthias;
    • Berek, Klaus;
    • Ladstätter, Felix;
    • Wurth, Sebastian;
    • Auer, Michael;
    • Di Pauli, Franziska;
    • Deisenhammer, Florian;
    • Berger, Thomas;
    • Teuchner, Barbara
    Publication type:
    Article
    27
    28

    From the ICL2012 Conference Chair.

    Published in:
    International Journal of Emerging Technologies in Learning, 2013, p. 4, doi. 10.3991/ijet.v8iS1.2417
    By:
    • Auer, Michael E.
    Publication type:
    Article
    29
    30

    From the ICL2008 Conference Chair.

    Published in:
    International Journal of Emerging Technologies in Learning, 2008, v. 3, n. S3, p. 4, doi. 10.3991/ijet.v3i1.765
    By:
    • Auer, Michael E.
    Publication type:
    Article
    31

    Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.

    Published in:
    2020
    By:
    • Andlauer, Till F. M.;
    • Link, Jenny;
    • Martin, Dorothea;
    • Ryner, Malin;
    • Hermanrud, Christina;
    • Grummel, Verena;
    • Auer, Michael;
    • Hegen, Harald;
    • Aly, Lilian;
    • Gasperi, Christiane;
    • Knier, Benjamin;
    • Müller-Myhsok, Bertram;
    • Jensen, Poul Erik Hyldgaard;
    • Sellebjerg, Finn;
    • Kockum, Ingrid;
    • Olsson, Tomas;
    • Pallardy, Marc;
    • Spindeldreher, Sebastian;
    • Deisenhammer, Florian;
    • Fogdell-Hahn, Anna
    Publication type:
    journal article
    32
    33
    34
    35
    36

    Serum hepcidin levels in multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319885984
    By:
    • Bsteh, Gabriel;
    • Haschka, David;
    • Tymoszuk, Piotr;
    • Berek, Klaus;
    • Petzer, Verena;
    • Hegen, Harald;
    • Wurth, Sebastian;
    • Auer, Michael;
    • Zinganell, Anne;
    • Di Pauli, Franziska;
    • Deisenhammer, Florian;
    • Weiss, Guenter;
    • Berger, Thomas
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.

    Published in:
    PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0170395
    By:
    • Link, Jenny;
    • Ramanujam, Ryan;
    • Auer, Michael;
    • Ryner, Malin;
    • Hässler, Signe;
    • Bachelet, Delphine;
    • Mbogning, Cyprien;
    • Warnke, Clemens;
    • Buck, Dorothea;
    • Hyldgaard Jensen, Poul Erik;
    • Sievers, Claudia;
    • Ingenhoven, Kathleen;
    • Fissolo, Nicolas;
    • Lindberg, Raija;
    • Grummel, Verena;
    • Donnellan, Naoimh;
    • Comabella, Manuel;
    • Montalban, Xavier;
    • Kieseier, Bernd;
    • Soelberg Sørensen, Per
    Publication type:
    Article
    43

    Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.

    Published in:
    PLoS Medicine, 2020, v. 17, n. 10, p. 1, doi. 10.1371/journal.pmed.1003348
    By:
    • Hässler, Signe;
    • Bachelet, Delphine;
    • Duhaze, Julianne;
    • Szely, Natacha;
    • Gleizes, Aude;
    • Hacein-Bey Abina, Salima;
    • Aktas, Orhan;
    • Auer, Michael;
    • Avouac, Jerôme;
    • Birchler, Mary;
    • Bouhnik, Yoram;
    • Brocq, Olivier;
    • Buck-Martin, Dorothea;
    • Cadiot, Guillaume;
    • Carbonnel, Franck;
    • Chowers, Yehuda;
    • Comabella, Manuel;
    • Derfuss, Tobias;
    • De Vries, Niek;
    • Donnellan, Naoimh
    Publication type:
    Article
    44

    Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.

    Published in:
    2020
    By:
    • Hässler, Signe;
    • Bachelet, Delphine;
    • Duhaze, Julianne;
    • Szely, Natacha;
    • Gleizes, Aude;
    • Hacein-Bey Abina, Salima;
    • Aktas, Orhan;
    • Auer, Michael;
    • Avouac, Jerôme;
    • Birchler, Mary;
    • Bouhnik, Yoram;
    • Brocq, Olivier;
    • Buck-Martin, Dorothea;
    • Cadiot, Guillaume;
    • Carbonnel, Franck;
    • Chowers, Yehuda;
    • Comabella, Manuel;
    • Derfuss, Tobias;
    • De Vries, Niek;
    • Donnellan, Naoimh
    Publication type:
    journal article
    45
    46
    47
    48
    49
    50